The Medtech Early Technical Assessment (META) tool has been selected, as an option, to form part of the application process for a £1 million grant. This follows the recent announcement from the Office for Life Sciences, in partnership with Innovate UK, to invest up to to £1 million to help small and medium sized companies generate evidence for their new innovative medicines, diagnostics and devices.
The NICE META tool provides a structured framework to help identify potential gaps in product development plans and next steps to help bring a product to market and the NICE META tool is recommended, as an option, to help with this part of the application.
MAP MedTech has been trained to facilitate the use of the META tool, on behalf of NICE. For more information about our META service, click here.
The closing date for applications for the grant is Wednesday, 21 March.